Hims & Hers (HIMS) is down -28.3%, or -$18.15 to $46.07.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers falls 10% in pre-market trading
- Hims & Hers plunges after Novo Nordisk terminates collaboration
- Novo Nordisk terminates collaboration with Hims & Hers Health
- Hims & Hers core revenue growth has ‘slowed sharply,’ says BofA
- Hims & Hers Stock (HIMS) Collapses 30% After Novo Nordisk Pulls Wegovy Deal on Safety Fears